Lung Disease Inhalers Increase Risk Of Heart Attack, Stroke

September 24, 2008

A new study has shown that inhalers such as Atrovent and Spiriva, used to treat lung disease such as chronic obstructive pulmonary disease, or COPD, increase the risk of heart attack and stroke in patients..Washington (ChattahBox) – A new study has shown that inhalers such as Atrovent and Spiriva, used to treat lung disease such as chronic obstructive pulmonary disease, or COPD, increase the risk of heart attack and stroke in patients.

The two inhalers in question here include ipratropium or Atrovent and tiotropium or Spiriva.

These drugs are helpful for those who have chronic lung disease.

Researchers were led by Dr. Sonal Singh of Wake Forest University.

For the study, they looked over 17 different clinical trials which involved over 14,000 patients with COPD.

The drugs were found to increase the risk of cardiac death by 80% and the risk of heart attack jumped by 53%.

The study was published in the Journal of the American Medical Association.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.